tiprankstipranks
Trending News
More News >
Innate Pharma SA (IPHYF)
OTHER OTC:IPHYF

Compare Innate Pharma SA (IPHYF) vs. Competitors

Compare
27 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Innate Pharma SA
$2.16
$125.11M
-1.52
-25.69%
Genfit
$10.88
$524.75M
-4.08
200.55%
1 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies
€3.36
€946.19M
-1.44
284.83%
1 Buy
0 Hold
0 Sell
Moderate Buy
Nanobiotix
€28.20
€1.33B
-9.10
650.14%
1 Buy
0 Hold
0 Sell
Moderate Buy
OSE Immunotherapeutics SA
€5.12
€78.06M
-1.87
-46.26%
Sensorion SAS
€0.65
€315.02M
-3.44
24.22%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
IPHYF
Innate Pharma SA
2.16
-0.75
-25.69%
GNFTF
Genfit
10.88
7.29
203.06%
GB:0QAJ
DBV Technologies
3.38
2.49
280.50%
GB:0QAV
Nanobiotix
27.20
23.78
694.39%
DE:6OP
OSE Immunotherapeutics SA
3.49
-2.99
-46.17%
DE:RFM
Sensorion SAS
0.64
0.14
27.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts